{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T22:26:11Z","timestamp":1769207171821,"version":"3.49.0"},"reference-count":42,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T00:00:00Z","timestamp":1474329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec><jats:label\/><jats:p>In the last few months, a new Zika virus (ZIKV) outbreak evolved in America. In accordance, World Health Organization (WHO) in February 2016 declared it as Public Health Emergency of International Concern (PHEIC). ZIKV infection was reported in more than 60 countries and the disease was spreading since 2007 but with little momentum. Many antiviral drugs are available in market or in laboratories under clinical trials, could affect ZIKV infection. In silico docking study were performed on the ZIKV polymerase to test some of Hepatitis C Virus (HCV) drugs (approved and in clinical trials). The results show potency of almost all of the studied compounds on ZIKV polymerase and hence inhibiting the propagation of the disease. In addition, the study suggested two nucleotide inhibitors (IDX\u2010184 and MK0608) that may be tested as drugs against ZIKV infection. <jats:bold><jats:italic>J. Med. Virol. 88:2044\u20132051, 2016<\/jats:italic>.<\/jats:bold> \u00a9 2016 Wiley Periodicals, Inc.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jmv.24678","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T18:31:13Z","timestamp":1473273073000},"page":"2044-2051","source":"Crossref","is-referenced-by-count":72,"title":["Zika viral polymerase inhibition using anti\u2010HCV drugs both in market and under clinical trials"],"prefix":"10.1002","volume":"88","author":[{"given":"Abdo A.","family":"Elfiky","sequence":"first","affiliation":[{"name":"Faculty of Science, Biophysics Department Cairo University Giza Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,9,20]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.04.042"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-009-0500-z"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrev.5b00664"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(56)90029-3"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2011.06.079"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2007.04.016"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(03)00028-7"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(52)90042-4"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0805715"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-016-1533-y"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10930-013-9462-9"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1166\/jctn.2015.3739"},{"key":"e_1_2_6_14_1","volume-title":"Hepatitis C viral polymerase inhibition using directly acting antivirals, a computational approach. software and techniques for bio\u2010molecular modeling","author":"Elfiky AA"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.4.1902-1909.2005"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i4.1421"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002681"},{"key":"e_1_2_6_18_1","first-page":"69","article-title":"Twelve isolations of Zika Virus from Aedes (Stegomyla) africanus (Theobald) taken in and above a Uganda Forest","volume":"31","author":"Haddow AJ","year":"1964","journal-title":"Bull Wid Hith Org"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001477"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.011"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2015.053"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-006-0903-z"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES2014.19.4.20683"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1408.080287"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2010.02.003"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81350-1"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(54)90006-1"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1600651"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12707"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(81)90100-0"},{"key":"e_1_2_6_31_1","unstructured":"1.7.6 V. The PyMOL Molecular Graphics System Version 1.7.6 Schr\u00f6dinger LLC."},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gku316"},{"key":"e_1_2_6_33_1","article-title":"The clinically approved antiviral drug sofosbuvir impairs Brazilian zika virus replication","author":"Sacramento CQ","year":"2016","journal-title":"bioRxiv"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1166\/jctn.2014.3392"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1166\/jctn.2015.3738"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(12)60010-5"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2011.75"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.07.141"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1631\/jzus.B1100120"},{"key":"e_1_2_6_40_1","unstructured":"WHO.2016. Zika strategic response framework and joint operations plan January\u2013June 2016."},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2006.08.056"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coviro.2011.10.019"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.02.1007"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.24678","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.24678","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T07:08:14Z","timestamp":1696403294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.24678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,20]]},"references-count":42,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["10.1002\/jmv.24678"],"URL":"https:\/\/doi.org\/10.1002\/jmv.24678","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,20]]}}}